Robert Henry Laugen, MD | |
12615 E Mission Ave, Suite 200, Spokane Valley, WA 99216-1047 | |
(509) 228-1200 | |
(509) 252-9300 |
Full Name | Robert Henry Laugen |
---|---|
Gender | Male |
Speciality | Internal Medicine - Hematology & Oncology |
Location | 12615 E Mission Ave, Spokane Valley, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548259740 | NPI | - | NPPES |
000010140038 | Other | BLUE SHIELD OF IDAHO | |
K4752 | Other | BLUE CROSS OF IDAHO | |
110050987 | Other | RAILROAD MEDICARE | |
7633LA | Other | ASURIS NW HEALTH | |
003217200 | Medicaid | ID | |
4021022 | Other | AETNA | |
1557008 | Medicaid | WA | |
37315 | Other | VI | LABOR & INDUSTRIES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | MD00016539 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert Henry Laugen, MD Po Box 3868, Spokane, WA 99220-3868 Ph: () - | Robert Henry Laugen, MD 12615 E Mission Ave, Suite 200, Spokane Valley, WA 99216-1047 Ph: (509) 228-1200 |
News Archive
Peering at microscopic changes within the retina, scientists in the Department of Ophthalmology at Weill Cornell Medical College in New York City, have discovered a key mechanism driving eye health and eye disease.
In the last several years, targeted therapies - drugs that directly impact specific genes and proteins involved in the progression of cancer - have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin cancer. Now, researchers at The Wistar Institute have discovered one way in which melanoma becomes resistant to a particular form of targeted therapy, and understanding this phenomenon may lead to a new melanoma target or prompt new designs of these treatments.
DaVita, announced that it has entered into a definitive agreement to acquire DSI Renal, for approximately $690 million, subject to adjustments. The company expects to close the transaction in the second or third quarter of this year.
The New York Times reports that "using medical devices and notebook computers, patients can see doctors without leaving home, and have the information automatically logged into electronic records."
A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state in which they are unable to proliferate.
› Verified 2 days ago
Dr. Paul Martin Craig, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 12401 E Sinto Ave, Spokane Valley, WA 99216 Phone: 509-922-2055 Fax: 509-922-2307 | |
Elizabeth Michelle Gunderson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1204 N Vercler Rd, Spokane Valley, WA 99216 Phone: 509-228-1000 Fax: 509-252-9300 | |
Dale A Nelson, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1215 N Mcdonald Rd, Ste 101, Spokane Valley, WA 99216 Phone: 509-924-1950 Fax: 509-921-0017 | |
Rita M Snow, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16528 E Desmet Ct Ste B3100, Spokane Valley, WA 99216 Phone: 509-944-9440 Fax: 509-227-7070 | |
Kristine J. Rinn, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1204 N Vercler Rd, Spokane Valley, WA 99216 Phone: 509-228-1000 Fax: 509-252-9300 | |
Kristina Kaneshiro Swiggum, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1215 N Mcdonald Rd, #101, Spokane Valley, WA 99216 Phone: 509-924-1950 Fax: 509-921-0017 | |
Andrew L. Kominsky, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 13424 E Mission Ave Ste A, Spokane Valley, WA 99216 Phone: 509-462-2273 Fax: 509-462-2275 |